Search results for "STATES"

showing 10 items of 1532 documents

Can eastern wisdom resolve western epidemics? Traditional Chinese medicine therapies and the opioid crisis.

2020

The widespread use of opioids to treat chronic pain led to a nation-wide crisis in the United States. Tens of thousands of deaths annually occur mainly due to respiratory depression, the most dangerous side effect of opioids. Non-opioid drugs and non-pharmacological treatments without addictive potential are urgently required. Traditional Chinese medicine (TCM) is based on a completely different medical theory than academic Western medicine. The scientific basis of acupuncture and herbal treatments as main TCM practices has been considerably improved during the past two decades, and large meta-analyses with thousands of patients provide evidence for their efficacy. Furthermore, opinion lead…

medicine.medical_specialtyModalitiesbusiness.industryChronic painAcupuncture TherapyGeneral MedicineTraditional Chinese medicinemedicine.diseaseUnited StatesScientific evidenceClinical trialAnalgesics OpioidOpioidAcupunctureMedicineHumansMedicine Chinese TraditionalOpioid EpidemicbusinessIntensive care medicineEpidemicsDepression (differential diagnoses)medicine.drugDrugs Chinese HerbalJournal of integrative medicine
researchProduct

Practical recommendations for the application of DE 59/2013

2019

The changes introduced with Council Directive 2013/59/Euratom will require European Member States adapt their regulations, procedures and equipment to the new high standards of radiation safety. These new requirements will have an impact, in particular, on the radiology community (including medical physics experts) and on industry. Relevant changes include new definitions, a new dose limit for the eye lens, non-medical imaging exposures, procedures in asymptomatic individuals, the use and regular review of diagnostic reference levels (including interventional procedures), dosimetric information in imaging systems and its transfer to the examination report, new requirements on responsibiliti…

medicine.medical_specialtyPopulationRadiation Dosage030218 nuclear medicine & medical imaging03 medical and health sciencesDose limit0302 clinical medicineOccupational ExposureLens CrystallinemedicineHumansRadiology Nuclear Medicine and imagingMedical physicsEuropean UnionEye lenseducationBSSEuropean Directive EuratomRadiodiagnostic and radiotherapeutic proceduresMedical exposureRadiation protectioneducation.field_of_studymedicine.diagnostic_testbusiness.industryMember statesInterventional radiologyGeneral MedicineRadiation ExposureReference StandardsDirective030220 oncology & carcinogenesisRadiological weaponAccidentalAsymptomatic DiseasesEmergenciesSafetyRadiologybusinessHealth PhysicsLa radiologia medica
researchProduct

Bibliometric analysis of leishmaniasis research in Medline (1945-2010)

2012

Background Publications are often used as a measure of success of research work. Leishmaniasis is considered endemic in 98 countries, most of which are developing. This article describes a bibliometric review of the literature on leishmaniasis research indexed in PubMed during a 66-year period. Methods Medline was used via the PubMed online service of the US National Library of Medicine. The search strategy was Leishmania [MeSH] or leishmaniasis [MeSH] from 1 January 1945 until 31 December 2010. Neither language nor document type restrictions were employed. Results A total of 20,780 references were retrieved. The number of publications increased steadily over time, with 3,380 publications f…

medicine.medical_specialtyPubMedBibliometric analysisAsiaBiomedical ResearchDiffuse cutaneous leishmaniasisMEDLINEOceaniaBibliometryMEDLINEBibliometricsLeishmaniasis cutaneousDiffuse cutaneous LeishmaniasismedicineAnimalsHumansLeishmaniasis visceralLeishmaniasisLeishmaniasis mucocutaneousPublishingLeishmaniaTraditional medicinebusiness.industryResearchScientific productionLeishmaniasismedicine.diseaseUnited StatesEuropeLatin AmericaInfectious DiseasesMappingBibliometricsFamily medicineAfricaNorth AmericaParasitologyPeriodicals as TopicbusinessScientific productionBrazilParasites & Vectors
researchProduct

Does prehospital care by physicians result in a better outcome than resuscitation by other EMS personnel?

1993

medicine.medical_specialtyResuscitationEmergency Medical Servicesbusiness.industryPublic healthResuscitationTreatment outcomeEmergency Nursingmedicine.diseaseOutcome (game theory)United StatesHeart ArrestEuropeEmergency Medical TechniciansTreatment OutcomePhysiciansEmergency MedicineEmergency medical servicesMedicineHumansWounds and InjuriesMedical emergencyCardiology and Cardiovascular MedicinebusinessIntensive care medicineResuscitation
researchProduct

Obesity and cardiovascular risk: the new public health problem of worldwide proportions

2004

Obesity could be considered a new global health epidemic above all others, especially when it is characterized by central fat distribution. This is illustrated by dramatic provisional data, indicating a continuous increase in the trend of overweight and obese individuals in several countries, including the USA and countries in Europe. Several epidemiological, pathophysiological and clinical studies clearly indicate that two of the major independent risk factors for cardiovascular disease or events are being overweight, and obesity. Accordingly, weight loss and prevention of weight gain has to be considered one of the most important strategies to reduce the incidence of cardiovascular diseas…

medicine.medical_specialtySettore MED/09 - Medicina InternaCoronary DiseaseHyperlipidemiasDiseaseOverweightGlobal HealthBody Mass IndexRisk FactorsWeight lossEnvironmental healthEpidemiologyInternal MedicinemedicineGlobal healthHumansObesityHeart Failurecardiovascular risk heart failure hypertension ischemic heart disease obesitybusiness.industryPublic healthGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityUnited StatesEuropeCardiovascular DiseasesHypertensionPhysical therapyAnti-Obesity Agentsmedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexExpert Review of Cardiovascular Therapy
researchProduct

US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids Pros and Cons, and a European …

2012

Prescriptions for opioid analgesics to manage moderate-to-severe chronic non-cancer pain have increased markedly over the last decade. An unintentional consequence of greater prescription opioid utilization has been the parallel increase in misuse, abuse and overdose, which are serious risks associated with all opioid analgesics. In response to disturbing rises in prescription opioid abuse, the US Food and Drug Administration (FDA) has proposed the implementation of aggressive Risk Evaluation and Mitigation Strategies (REMS). While REMS could dramatically change the development, release, marketing and prescription of extended-release opioids, questions remain on how these programmes may inf…

medicine.medical_specialtyTime FactorsSettore MED/41 - AnestesiologiaLong-Acting Opioids Food and drug administration AnalgesiaRisk AssessmentFood and drug administrationPatient safetyPharmacotherapymedicineHumansPharmacology (medical)Medical prescriptionIntensive care medicineUnited States Food and Drug Administrationbusiness.industryPerspective (graphical)Chronic painLong-Acting Opioids Food and drug administration AnalgesiaOpioid-Related Disordersmedicine.diseaseUnited StatesRisk evaluationAnalgesics OpioidEuropeDelayed-Action PreparationsMedical emergencyChronic PainRisk assessmentbusiness
researchProduct

Internet Addiction: Starting the Debate on Health and Well-Being of Children Overexposed to Digital Media.

2017

Previous articles published in the European Paediatric Association (EPA) pages have discussed the importance of children's well-being and its role in different areas of children's health, such as well-child care and child-friendly health care. The goal of this commentary is to raise pediatricians' awareness on the risks of children's overexposure to digital media. It is important to protect the psychological and emotional health of children from uncontrolled external influences to preserve their well-being. We also emphasize the importance of alerting parents and tutors to the risks related to the unrefrained use of the Internet.

medicine.medical_specialtymedia_common.quotation_subjectMEDLINEPediatricsChild healthDigital media03 medical and health sciences0302 clinical medicineMedicineHumansSocial media030212 general & internal medicinePsychiatryChildmedia_commonPsychiatric Status Rating ScalesInternetbusiness.industryComputersAddictionChild HealthUnited Stateschildren digital media health well-beingBehavior AddictivePediatrics Perinatology and Child HealthPsychiatric status rating scalesWell-beingThe InternetbusinessSocial Media030217 neurology & neurosurgeryThe Journal of pediatrics
researchProduct

Overview of Venous Thromboembolism

2010

Thrombosis occurs at sites of injury to the vessel wall, by inflammatory processes leading to activation of platelets, platelet adherence to the vessel wall and the formation of a fibrin network. A thrombus that goes on to occlude a blood vessel is known as a thromboembolism. Venous thromboembolism begins with deep vein thrombosis (DVT), which forms in the deep veins of the leg (calf) or pelvis. In some cases, the DVT becomes detached from the vein and is transported to the right-hand side of the heart, and from there to the pulmonary arteries, giving rise to a pulmonary embolism (PE). Certain factors predispose patients toward the development of venous thromboembolism (VTE), including surg…

medicine.medical_specialtymedicine.drug_classDeep veinFondaparinuxRisk FactorsmedicineHumansPharmacology (medical)cardiovascular diseasesThrombusIntensive care medicineVeinSocieties Medicalbusiness.industryAnticoagulantAnticoagulantsVenous Thromboembolismequipment and suppliesmedicine.diseaseThrombosisUnited StatesSurgeryPulmonary embolismVenous thrombosismedicine.anatomical_structurePractice Guidelines as Topicbusinessmedicine.drugDrugs
researchProduct

Prevalence of pulmonary embolism in 127 945 autopsies performed in cancer patients in the United States between 2003 and 2019

2021

Abstract Background Pulmonary embolism (PE) is a potentially fatal disease, but data on the incidence of fatal PE in cancer patients are scant. Objective We sought to estimate the proportion of cancer patients with PE at autopsy. Methods For this retrospective cohort study, all autopsy reports of cancer patients were retrieved from PALGA: Dutch Pathology Registry and used for data extraction. The primary outcome was PE at time of autopsy, defined as any clot obstructing a pulmonary artery. The secondary outcome was venous thromboembolism, defined as the composite of thrombotic PE, deep vein thrombosis, splanchnic vein thrombosis, or internal jugular vein thrombosis. Results A total of 9571 …

medicine.medical_specialtypulmonary embolismvenous thromboembolism2720 Hematology610 Medicine & healthAutopsyautopsyNeoplasmsInternal medicineEpidemiologyPrevalencemedicineHumanscancerbusiness.industry10031 Clinic for AngiologyCancerOriginal ArticlesHematologymedicine.diseasemortalityUnited StatesPulmonary embolismTHROMBOSISOriginal ArticleepidemiologybusinessJournal of Thrombosis and Haemostasis
researchProduct

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.

2015

Abstract: Introduction: The identification of cell membrane-bound molecules with a relevant role in cancer cell survival prompted the development of moAbs to block the related pathways. In the last few years, the number of approved moAbs for cancer treatment has constantly increased. Many of these drugs significantly improved the survival outcomes in patients with solid tumours. Areas covered: In this review, all the FDA-approved moAbs in solid tumours have been described. This is an update of moAbs available for cancer treatment nowadays in comparison with the moAbs approved until few years ago. The moAbs under development are also discussed here. Expert opinion: The research on cancer ant…

medicine.medical_treatmentClinical BiochemistryCellReceptor activator of nuclear factor κB ligandCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)NeoplasmsMonoclonalDrug DiscoveryDrug approvalCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all); Cancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)Drug ApprovalCancerbiologyMedicine (all)Antibodies MonoclonalVEGFReceptor activator of nuclear factor κB ligandmedicine.anatomical_structureMonoclonalMoAbsImmunotherapyAntibodyEngineering sciences. TechnologyHumanUnited StateCancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)medicine.drug_classEGFRMonoclonal antibodyAntibodiesCancer antigenCytotoxic T-lymphocyte antigen 4HER2medicineHumansBiologyPharmacologybusiness.industryUnited States Food and Drug AdministrationDrug Discovery3003 Pharmaceutical ScienceCancerImmunotherapymedicine.diseaseUnited StatesImmunologyCancer cellCancer researchbiology.proteinNeoplasmMoAbHuman medicinebusinessExpert opinion on biological therapy
researchProduct